William Jones's most recent trade in Corvus Pharmaceuticals Inc was a trade of 400,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corvus Pharma Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc | William Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 14,461 | 14,461 | - | - | Stock Option (Right to Buy) | |
| Annexon Inc | William Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Corvus Pharma Inc | William Benton Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. | 04 Jun 2025 | 19,357 | 173,130 (0%) | 0% | 3.5 | 67,750 | Common Stock |
| Corvus Pharma Inc | William Benton Jones | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2025 | 19,357 | 0 | - | - | Warrant (Right to Buy) | |
| Annexon Inc | William Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 88,000 | 88,000 | - | - | Stock Option (Right to Buy) | |
| NewAmsterdam Pharma Co NV | William Jones | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 43,000 | 43,000 | - | - | Ordinary Shares | |
| NewAmsterdam Pharma Co NV | William Jones | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 200,000 | 200,000 | - | - | Option (right to buy) | |
| Corvus Pharma Inc | Jones William Benton | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Apogee Therapeutics Inc | William B.J. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,370 | 10,370 | - | - | Stock Option (Right to Buy) | |
| Linkbancorp Inc | William L. Jones | Director | 23 May 2024 | 2,000 | 14,377 | - | 0 | Common Stock | ||
| Linkbancorp Inc | William L. Jones | Director | 16 May 2024 | 2,500 | 12,377 | - | 6.5 | 16,250 | Common Stock | |
| Corvus Pharma Inc | William Benton Jones | See Remarks | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 06 May 2024 | 20,000 | 153,773 (0%) | 0% | 1.7 | 34,624 | Common Stock |
| Corvus Pharma Inc | William Benton Jones | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 May 2024 | 19,357 | 19,357 | - | - | Warrant (Right to Buy) | |
| Corvus Pharma Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2023 | 200,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Thor Ind Inc | William R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2023 | 1,409 | 12,902 (0%) | 0% | 0 | Common Stock | |
| Linkbancorp Inc | William L. Jones | Director | 31 Aug 2023 | 2,000 | 9,877 | - | 0 | Common Stock | ||
| Akili Inc | William B.J. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.74 per share. | 20 Feb 2023 | 954 | 26,941 (0%) | 0% | 36.7 | 35,050 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2023 | 954 | 27,895 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2023 | 505 | 4,383 | - | - | Restricted Stock Units | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2023 | 449 | 11,691 | - | - | Restricted Stock Units | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 8,251 | 24,795 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.67 per share. | 03 Feb 2023 | 3,045 | 21,750 (0%) | 0% | 40.7 | 123,840 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 2,053 | 23,803 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 1,369 | 24,463 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 1,048 | 25,038 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.67 per share. | 03 Feb 2023 | 709 | 23,094 (0%) | 0% | 40.7 | 28,835 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 700 | 25,376 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.67 per share. | 03 Feb 2023 | 473 | 23,990 (0%) | 0% | 40.7 | 19,237 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.67 per share. | 03 Feb 2023 | 362 | 24,676 (0%) | 0% | 40.7 | 14,723 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.67 per share. | 03 Feb 2023 | 242 | 25,134 (0%) | 0% | 40.7 | 9,842 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 18,371 | 18,371 | - | - | Restricted Stock Units | |
| Corvus Pharma Inc | William Benton Jones | See Remarks | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 20 Dec 2022 | 20,000 | 133,773 (0%) | 0% | 0.8 | 15,800 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.60 per share. | 20 Nov 2022 | 7,195 | 16,544 (0%) | 0% | 35.6 | 256,142 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2022 | 7,195 | 20,000 | - | - | Restricted Stock Units | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2022 | 7,195 | 23,739 (0%) | 0% | 0 | Common Stock | |
| Akili Inc | William B.J. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Thor Ind Inc | William R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2022 | 1,658 | 11,493 (0%) | 0% | 0 | Common Stock | |
| Linkbancorp Inc | William L. Jones | Director | 14 Sep 2022 | 571 | 7,877 | - | 7.5 | 4,283 | Common Stock | |
| Corvus Pharma Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2022 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Alto Ingredients Inc | William L. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 26,965 | 210,353 (0%) | 0% | 0 | Common Stock | |
| Biogen | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 2,145 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 168 | 4,400 | - | - | Restricted Stock Units | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.45 per share. | 20 May 2022 | 168 | 3,739 (0%) | 0% | 38.5 | 6,460 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2022 | 168 | 3,907 (0%) | 0% | 0 | Common Stock | |
| Sempra Energy | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 34 | 35,781 | - | - | Phantom Shares | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 3,933 | 3,933 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.15 per share. | 04 Feb 2022 | 1,475 | 2,458 (0%) | 0% | 62.1 | 91,671 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 880 | 3,338 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 587 | 3,621 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.15 per share. | 04 Feb 2022 | 304 | 3,034 (0%) | 0% | 62.2 | 18,894 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.15 per share. | 04 Feb 2022 | 202 | 3,419 (0%) | 0% | 62.1 | 12,554 | Common Stock |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 12,990 | 12,990 | - | - | Restricted Stock Units | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 5,845 | 5,845 | - | - | Restricted Stock Units | |
| Sempra Energy | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 94 | 35,461 | - | - | Phantom Shares | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Sale of securities on an exchange or to another person at price $ 69.16 per share. | 23 Nov 2021 | 12,885 | 0 (0%) | 0% | 69.2 | 891,149 | Common Stock |
| Thor Ind Inc | William R. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2021 | 1,615 | 9,835 (0%) | 0% | 0 | Common Stock | |
| Sempra Energy | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 99 | 35,068 | - | - | Phantom Shares | |
| Corvus Pharma Inc | William Benton Jones | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Biogen | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 775 (0%) | 0% | 0 | Common Stock | |
| Sempra Energy | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 93 | 34,679 | - | - | Phantom Shares | |
| Alto Ingredients Inc | William L. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 23,867 | 183,388 (0%) | 0% | 0 | Common Stock | |
| MaxLinear Inc | William Kelly Jones | VP of Worldwide Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 4,888 | 4,888 | - | - | Restricted Stock Units | |
| Sempra Energy | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 833 | 4,983 (0%) | 0% | 0 | Common Stock | |
| Sempra Energy | William D. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 94 | 34,311 | - | - | Phantom Shares | |
| Alto Ingredients Inc | William L. Jones | Director | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 17 Mar 2021 | 20,000 | 159,521 (0%) | 0% | 6.0 | 119,600 | Common Stock |